FDA Inspection 1151264 — South Florida Institute for Reproductive Medicine
The FDA completed an inspection of South Florida Institute for Reproductive Medicine on September 1, 2021 in Naples, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 1, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Naples, FL (United States)